Jeremy C McMurray, Curtis S Pacheco, Brandon J Schornack, Xiaoping Sun, Janet A Brunader, Alexis Erica Scott, Juan S Ariza, Chung-Ting J Kou, Ryan C Costantino, Luke M Pittman, Karla E Adams, Aubri M Waters, Eric M Pryor, Jonathan J Lyons, Dean Metcalfe, Irina Maric, Nathan A Boggs
Timely diagnosis of systemic mastocytosis (SM) remains challenging due to care heterogeneity. We implemented a standardized approach for SM screening and diagnosis utilizing a novel healthcare system-wide international screening registry. A retrospective analysis assessed rates of SM, cutaneous mastocytosis (CM), and molecular diagnoses before and two years after care standardization. Accuracy of individual and combined SM screening tests - basal serum tryptase (BST) ≥11.5 and ≥20.0 ng/mL, REMA ≥2, monomorphic maculopapular CM, and elevated BST based upon tryptase genotype - was analyzed...
April 18, 2024: Blood